How does the FDA address the challenge of emerging contaminants?
Emerging contaminants, such as new industrial chemicals and pharmaceuticals entering the environment, pose a significant challenge. The FDA collaborates with other agencies, such as the EPA, to monitor and assess potential health impacts. The FDA conducts toxicological evaluations and develops guidelines to manage risks associated with these contaminants, ensuring that consumer safety remains paramount.
